MARK MCDADE
CIK 1242126 · CEO · last filed 2025-10-28
MARK MCDADE is a CEO who has filed 51 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for TRML, was dated Oct 28, 2025. Across all open-market trades the lifetime net is +$1.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $38.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$38.0K
10
51
$1.79M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Tourmaline Bio, Inc. (TRML) Delisted | Director | 0 | $47.98 | $0 | $3.25M | 4 | 2025-10-28 |
| Icosavax, Inc. (ICVX) Delisted | Director | 0 | $15.31 | $0 | $299.8K | 4 | 2024-02-20 |
| Tourmaline Bio, Inc. (TALS) Delisted | Director | — | $27.20 | — | $0 | 2 | 2023-06-14 |
| COLL | Director | 0 | $34.64 | $0 | $0 | 6 | 2020-10-14 |
| DERM | Director | 6,000 | $6.34 | $38.0K | $0 | 6 | 2019-06-14 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Director | 10,162 | $178.75 | $1.82M | $0 | 4 | 2018-05-14 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Director | — | $38.00 | — | $0 | 2 | 2016-03-17 |
| Aimmune Therapeutics, Inc. (AIMT) Delisted | Director | 16,660 | — | — | $266.6K | 1 | 2015-08-11 |
| CYTK | Director | — | $70.15 | — | $0 | 4 | 2009-05-22 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | CEO | 46,275 | — | — | -$2.03M | 9 | 2007-07-24 |
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-28 | Tourmaline Bio, Inc. (TRML) Delisted | Mixed | −742,209 | $0 | EDGAR |
| 2025-06-06 | Tourmaline Bio, Inc. (TRML) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | Tourmaline Bio, Inc. (TRML) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-20 | Icosavax, Inc. (ICVX) Delisted | Mixed | −3,566,014 | $0 | EDGAR |
| 2024-01-31 | Tourmaline Bio, Inc. (TRML) Delisted | Buy (P) | +100,000 | $3.25M | EDGAR |
| 2023-10-23 | — | Mixed | +348,949 | $0 | |
| 2023-06-14 | Tourmaline Bio, Inc. (TALS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | Icosavax, Inc. (ICVX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-14 | Icosavax, Inc. (ICVX) Delisted | Grant (A) | +5,543 | $0 | EDGAR |
| 2022-06-13 | Tourmaline Bio, Inc. (TALS) Delisted | Grant (A) | — | $0 | EDGAR |